|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.690 AUD | -0.42% |
|
-3.30% | -2.09% |
| 11-19 | Medibank Private Limited Approves the Election of Dr. Lisa Mcintyre and Jacqueline Hey as Director | CI |
| 11-19 | Medibank Private Limited - Shareholder/Analyst Call |
| Capitalization | 12.92B 8.63B 7.44B 6.93B 6.45B 12B 783B 79.67B 31.41B 373B 32.36B 31.7B 1,364B | P/E ratio 2026 * |
19.7x | P/E ratio 2027 * | 18.5x |
|---|---|---|---|---|---|
| Enterprise value | 12.54B 8.38B 7.22B 6.72B 6.26B 11.65B 760B 77.33B 30.49B 363B 31.41B 30.77B 1,324B | EV / Sales 2026 * |
1.38x | EV / Sales 2027 * | 1.31x |
| Free-Float |
99.88% | Yield 2026 * |
4.05% | Yield 2027 * | 4.37% |
Last Transcript: Medibank Private Limited
| 1 day | -0.42% | ||
| 1 week | -3.30% | ||
| Current month | -2.09% | ||
| 1 month | -2.09% | ||
| 3 months | -2.09% | ||
| 6 months | -8.04% | ||
| Current year | -2.09% |
| 1 week | 4.65 |  | 4.89 |
| 1 month | 4.64 | | 4.89 |
| Current year | 4.64 | | 4.89 |
| 1 year | 3.78 | | 5.31 |
| 3 years | 2.86 | | 5.31 |
| 5 years | 2.7 | | 5.31 |
| 10 years | 2.1 | | 5.31 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Koczkar
CEO | Chief Executive Officer | 53 | 16/05/2021 |
Mark Rogers
DFI | Director of Finance/CFO | - | 31/12/2016 |
Felicia Trewin
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
David Koczkar
BRD | Director/Board Member | 53 | 16/05/2021 |
| Chairman | 69 | 29/09/2020 | |
Tracey Batten
BRD | Director/Board Member | 59 | 27/07/2017 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -.--% | 0.9% | 0 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.42% | -3.30% | +24.07% | +62.28% | 8.63B | |
| -2.69% | -0.22% | -35.51% | -9.34% | 5.32B | |
| -4.99% | -6.66% | +10.70% | +451.67% | 4.38B | |
| -2.49% | +0.35% | -25.16% | +74.32% | 4.58B | |
| -0.30% | -2.92% | +21.53% | -13.05% | 2.17B | |
| -0.47% | -0.71% | -4.13% | - | 1.6B | |
| -4.34% | -9.79% | -33.13% | -40.61% | 1.4B | |
| +0.32% | +1.32% | - | - | 940M | |
| -1.14% | -2.56% | -12.87% | +39.35% | 883M | |
| Average | -1.84% | -2.62% | -6.81% | +80.66% | 3.32B | |
| Weighted average by Cap. | -1.99% | -2.52% | -2.33% | +100.66% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 9.1B 6.08B 5.24B 4.88B 4.54B 8.46B 552B 56.12B 22.13B 263B 22.8B 22.33B 961B | 9.52B 6.36B 5.48B 5.1B 4.75B 8.85B 577B 58.71B 23.15B 275B 23.85B 23.36B 1,005B |
| Net income | 653M 436M 376M 350M 326M 607M 39.57B 4.03B 1.59B 18.87B 1.64B 1.6B 68.92B | 698M 467M 402M 374M 349M 649M 42.33B 4.31B 1.7B 20.19B 1.75B 1.71B 73.73B |
| Net Debt | -379M -253M -218M -203M -189M -352M -22.98B -2.34B -922M -10.96B -950M -930M -40.02B | -443M -296M -255M -237M -221M -412M -26.85B -2.73B -1.08B -12.81B -1.11B -1.09B -46.76B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/01/26 | 4.690 $ | -0.42% | 6,198,598 |
| 15/01/26 | 4.710 $ | -0.21% | 4,903,128 |
| 14/01/26 | 4.720 $ | -0.63% | 5,585,968 |
| 13/01/26 | 4.750 $ | 0.00% | 4,933,131 |
| 12/01/26 | 4.750 $ | -2.06% | 5,414,463 |
Delayed Quote Australian S.E., January 16, 2026 at 05:10 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MPL Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition